Abstract

Kinesins are motor proteins present in organisms from protists to mammals playing important roles in cell division, intracellular organisation and flagellum formation and maintenance. Leishmania mexicana is a protozoan parasite of the order Kinetoplastida causing human cutaneous leishmaniasis. Kinetoplastida genome sequence analyses revealed a large number of kinesins showing sequence and structure homology to eukaryotic kinesins. Here, we investigate the L. mexicana kinesin LmxKIN29 (LmxM.29.0350), also called DEATH kinesin. The activated MAP kinase LmxMPK3, a kinase affecting flagellum length in Leishmania, is able to phosphorylate recombinant full length LmxKIN29 at serine 554. Insect promastigote LmxKIN29 Leishmania null mutants showed no obvious phenotype. However, in mouse infection experiments, the null mutants were unable to cause the disease, whereas LmxKIN29 add-backs and single allele knockouts caused footpad lesions. Localisation using promastigotes expressing GFP-tagged LmxKIN29 revealed that the kinesin is predominantly found in between the nucleus and the flagellar pocket, while in dividing cells the GFP-fusion protein was found at the anterior and posterior ends of the cells indicating a role in cytokinesis. The inability to cause lesions in infected animals and the amino acid sequence divergence from mammalian kinesins suggests that LmxKIN29 is a potential drug target against leishmaniasis.

Details

Title
Absence of DEATH kinesin is fatal for Leishmania mexicana amastigotes
Author
Al Kufi Suad Gazi Jaafer Husaine 1 ; Emmerson Josiah 2 ; Rosenqvist, Heidi 2 ; Garcia Catarina Mateus Moreira 2 ; Rios-Szwed, Diana Onodelia 3 ; Wiese, Martin 2 

 University of Strathclyde, Strathclyde Institute of Pharmacy and Biomedical Sciences, Glasgow, UK (GRID:grid.11984.35) (ISNI:0000000121138138); University of Kufa, Department of Laboratory Investigations, Faculty of Science, Kufa, Iraq (GRID:grid.442852.d) (ISNI:0000 0000 9836 5198) 
 University of Strathclyde, Strathclyde Institute of Pharmacy and Biomedical Sciences, Glasgow, UK (GRID:grid.11984.35) (ISNI:0000000121138138) 
 University of Strathclyde, Strathclyde Institute of Pharmacy and Biomedical Sciences, Glasgow, UK (GRID:grid.11984.35) (ISNI:0000000121138138); University of Edinburgh, MRC Human Genetics Unit, Institute of Genetics and Cancer, Edinburgh, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2634291639
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.